Arius Research

Biotechnology company developing antibody therapeutics.

Launch date

1999

Employees

Market cap

Enterprise valuation

$189m (Public information from Jul 2008)

Toronto Ontario (HQ)

Date	Investors	Amount	Round
Nov 2005	N/A	$2.0m	Early VC
Mar 2006	N/A	$21.5m	Early VC
Jul 2008	Roche	$189m Valuation: $189m	Acquisition
Total Funding		$23.5m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Arius Research